OSCR

Multi-regional transcriptomic analysis reveals early nociceptive and neuroinflammatory alterations in APP/PS1 mice.

Overview

Authors: Zhutao Sheng1, Fu Xu1, Yuqing Yan1, Ling Chen1, Baomin Dou1, Na Liu2, Sicheng Zhou1,2, Xiongwei Zhu3, Yuan-Xiang Tao1, Ying Xu1
  1. Department of Anesthesiology, Rutgers, the State University of New Jersey, Newark, NJ, United States
  2. Department of Pharmaceutical Sciences, School of Pharmacy, University at Buffalo, The State University of New York, Buffalo, NY, United States
  3. Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, United States
Journal: Frontiers in immunology, volume 17, article 1937738
Dates: received 14 July 2026; accepted 10 August 2026; published online 26 August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fimmu.2026.1937738 · PMID 42718603 · PMCID PMC13553343 · OpenAlex W7204248434
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), mouse (organism), Alzheimer's / dementia (population), pain (population), cellular / molecular (subfield)
Methods: Statistics, Machine learning, fMRI & imaging
Keywords: Alzheimer’s disease, amyloid plaques, memory impairment, neuroinflammation, nociceptive hypersensitivity
MeSH: Alzheimer Disease*, Amyloid beta-Protein Precursor*, Neuroinflammatory Diseases*, Nociception*, Transcriptome*, Animals, Disease Models, Animal, Gene Expression Profiling, Male, Mice, Mice, Transgenic, Plaque, Amyloid, Presenilin-1 (* major topic)
Topic: Pain Mechanisms and Treatments (Physiology, Medicine), according to OpenAlex
Funding: NIA NIH HHS (R01 AG070873)
Citations: not cited yet (Europe PMC); 75 references in the paper

Abstract

Background: BackgroundAlzheimer's disease (AD) is characterized by progressive cognitive decline and neuropsychiatric symptoms, including chronic neuropathic pain. However, the molecular mechanisms linking pain sensitivity to early AD pathology remain poorly understood.

Methods: In the present study, 4- to 5-month-old APP/PS1 mice were used to identify molecular signatures of the early pathological stage. Transcriptomic analysis, quantitative real-time RT-PCR (qRT-PCR), immunoblot, and ELISA analyses were performed to assess region-specific gene expression, neuroinflammation, and synaptic protein levels in pain-related regions.

Results: Although memory behaviors remained unchanged in 4–5-month-old APP/PS1 mice, these mice showed an increase in whole-brain Aβ plaque burden. Transcriptomic analysis and qRT-PCR revealed distinct region-specific gene expression changes. Plin4 was downregulated in the DRG, spinal cord, thalamus, and hippocampus of APP/PS1 mice. Rps3a3 and Prnp were significantly upregulated in both the spinal cord and thalamus, whereas Hif3a and Serpina3f were significantly upregulated in the thalamus and hippocampus. These gene alterations were closely involved in inflammatory responses and synaptic plasticity. Immunoblot and ELISA analyses in these pain-related regions demonstrated increased TNF-α and IL-1β levels, as well as reduced expression of synaptic proteins, indicating enhanced neuroinflammation and synaptic loss in the early stages of APP/PS1 mice.

Conclusion: These findings support the presence of neuroinflammation and synaptic dysfunction in pain-processing circuits as early molecular events in APP/PS1 mice, suggesting that nociceptive alterations may represent an early feature of the pathological stage of AD.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The datasets presented in this study can be found in online repositories (https://doi.org/10.5281/zenodo.17517310). The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 10 authors, 5 keywords, 13 MeSH terms, 1 funder, 74 references, 2 RRIDs.

Cite

This paper

Sheng, Z., Xu, F., Yan, Y., Chen, L., Dou, B., Liu, N., Zhou, S., Zhu, X., Tao, Y.-X., & Xu, Y. (2026). Multi-regional transcriptomic analysis reveals early nociceptive and neuroinflammatory alterations in APP/PS1 mice. Frontiers in immunology, 17, 1937738. https://doi.org/10.3389/fimmu.2026.1937738

BibTeX

@article{sheng2026multi,
author = {Sheng, Zhutao and Xu, Fu and Yan, Yuqing and Chen, Ling and Dou, Baomin and Liu, Na and Zhou, Sicheng and Zhu, Xiongwei and Tao, Yuan-Xiang and Xu, Ying},
title = {{Multi-regional transcriptomic analysis reveals early nociceptive and neuroinflammatory alterations in APP/PS1 mice}},
journal = {Frontiers in immunology},
year = {2026},
month = aug,
volume = {17},
pages = {1937738},
publisher = {Frontiers Media SA},
issn = {1664-3224},
doi = {10.3389/fimmu.2026.1937738},
url = {https://doi.org/10.3389/fimmu.2026.1937738},
pmid = {42718603},
pmcid = {PMC13553343}
}

RIS

TY - JOUR
AU - Sheng, Zhutao
AU - Xu, Fu
AU - Yan, Yuqing
AU - Chen, Ling
AU - Dou, Baomin
AU - Liu, Na
AU - Zhou, Sicheng
AU - Zhu, Xiongwei
AU - Tao, Yuan-Xiang
AU - Xu, Ying
TI - Multi-regional transcriptomic analysis reveals early nociceptive and neuroinflammatory alterations in APP/PS1 mice
T2 - Frontiers in immunology
J2 - Front Immunol
PY - 2026
DA - 2026/08/26
VL - 17
SP - 1937738
SN - 1664-3224
PB - Frontiers Media SA
DO - 10.3389/fimmu.2026.1937738
UR - https://doi.org/10.3389/fimmu.2026.1937738
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fimmu.2026.1937738",
"type": "article-journal",
"title": "Multi-regional transcriptomic analysis reveals early nociceptive and neuroinflammatory alterations in APP/PS1 mice",
"container-title": "Frontiers in immunology",
"author": [
{
"family": "Sheng",
"given": "Zhutao"
},
{
"family": "Xu",
"given": "Fu"
},
{
"family": "Yan",
"given": "Yuqing"
},
{
"family": "Chen",
"given": "Ling"
},
{
"family": "Dou",
"given": "Baomin"
},
{
"family": "Liu",
"given": "Na"
},
{
"family": "Zhou",
"given": "Sicheng"
},
{
"family": "Zhu",
"given": "Xiongwei"
},
{
"family": "Tao",
"given": "Yuan-Xiang"
},
{
"family": "Xu",
"given": "Ying"
}
],
"container-title-short": "Front Immunol",
"volume": "17",
"page": "1937738",
"DOI": "10.3389/fimmu.2026.1937738",
"PMID": "42718603",
"PMCID": "PMC13553343",
"ISSN": "1664-3224",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fimmu.2026.1937738",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
26
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41419-026-08791-1
The PM20D1-OLE pathway induces microglia rewiring to ameliorate Alzheimer disease.
Journal: Cell death & disease
In common: NCBI GEO GSE33000, Alzheimer's / dementia, genetics / omics, mouse, 1 other category
[2] doi:10.1038/s41467-026-75895-9
Distinct Filament Conformation for Receptor-Bound Amyloid-β from Alzheimer's Disease Brain.
Journal: Nature communications
In common: Alzheimer's / dementia, cellular / molecular, 3 references
[3] doi:10.3390/ijms27146196
Investigation of the Potential Neuroprotective Mechanisms of <i>Acalypha indica</i> Against Alzheimer's Disease by Integrated Bioinformatics Analysis.
Journal: International journal of molecular sciences
In common: NCBI GEO GSE33000, Alzheimer's / dementia, genetics / omics, cellular / molecular
[4] doi:10.3390/biomedicines14050998 [code]
Integrative Multi-Omics and Machine Learning Analysis Identifies Therapeutic Targets and Drug Repurposing Candidates for Alzheimer's Disease.
Journal: Biomedicines
In common: NCBI GEO GSE33000, Alzheimer's / dementia, genetics / omics, cellular / molecular
[5] doi:10.1016/j.apsb.2026.04.017
PYGL-driven glycogenolysis impairs microglial autophagic flux <i>via</i> SNAP29 <i>O</i>-GlcNAcylation in Alzheimer's disease.
Journal: Acta pharmaceutica Sinica. B
In common: NCBI GEO GSE33000, Alzheimer's / dementia, cellular / molecular
[6] doi:10.1016/j.ynirp.2026.100366 [code]
Lower resting-state functional connectivity between frontoparietal and sensory networks is associated with recent pain intensity in a community sample of youth.
Journal: Neuroimage. Reports
In common: pain, 2 references
[7] doi:10.1038/s41467-026-71963-2 [code]
Spinal cord structural and functional architecture and its shared organization with the brain across the adult lifespan.
Journal: Nature communications
In common: 2 references
[8] doi:10.1186/s13024-026-00946-0
Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer's knock-in mouse phenotypes.
Journal: Molecular neurodegeneration
In common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 1 reference
[9] doi:10.1172/jci.insight.191905
The contribution of stem cell factor and its receptor c-Kit to cancer-induced bone pain.
Journal: JCI insight
In common: pain, mouse, cellular / molecular, 1 reference
[10] doi:10.3390/antiox15070807
Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway.
Journal: Antioxidants (Basel, Switzerland)
In common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.